Showing 321 - 340 results of 66,330 for search '(( 50 mg decrease ) OR ( 5 ((non decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 0.93s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330
  11. 331
  12. 332

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  13. 333
  14. 334

    CM-DWM-EC chart using 30% decrease in the mean for the E(KeV). by Shumaila Nisar (20114256)

    Published 2024
    “…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340